Tafenoquine
Catalog No. A12873
Tafenoquine是由葛兰素史克(GlaxoSmithKline)生产的8-氨基喹啉药物,目前正在研究其作为疟疾和疟疾预防的潜在疗法。
Catalog Num | A12873 |
---|---|
M. Wt | 463.49 |
Formula | C24H28F3N3O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 106635-80-7 |
Synonyms | WR 238605, WR238605, WR-238605, SB-252263, SB 252263, SB252263 |
SMILES | CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC |
Tafenoquine是由葛兰素史克(GlaxoSmithKline)生产的8-氨基喹啉药物,目前正在研究其作为疟疾和疟疾预防的潜在疗法。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.58 mL | 107.88 mL | 215.75 mL |
0.5 mM | 4.32 mL | 21.58 mL | 43.15 mL |
1 mM | 2.16 mL | 10.79 mL | 21.58 mL |
5 mM | 0.43 mL | 2.16 mL | 4.32 mL |
*The above data is based on the productmolecular weight 463.49. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.